Home › NCT02812290

Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation

Multi-Centric Observational Study to Analyze the Diagnostic Molecular Features in the Clinical Setting of Lung Allograft Biopsies

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* All lung transplant recipients undergoing a biopsy as determined by their surgeon or physician.

Exclusion Criteria:

* Patients who declined participation or unable to give informed consent.

About the study

Objective: To evaluate the potential impact of molecular phenotyping of transbronchial biopsies in lung transplant recipients with allograft dysfunction, and the potential for developing a safer endobronchial mucosal biopsy format.

What is being tested

• Lung transplant biopsy bites. (procedure)

Sponsor: University of Alberta · Participants: 700 · Started: 2016-05

Contact the study team

• Konrad S Famulski, PhD · Phone: 1 780 492 1725
• Robert Polakowski, PhD · Phone: 1 780 492 5091

Official record on ClinicalTrials.gov — NCT02812290

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.